• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ARCA biopharma Inc

+ Add to Watchlist

ABIO:US

0.7200 USD 0.0200 2.86%

As of 20:10:00 ET on 01/26/2015.

Snapshot for ARCA biopharma Inc (ABIO)

Open: 0.7100 Day's Range: 0.6900 - 0.7450 Volume: 193,364
Previous Close: 0.7000 52wk Range: 0.6878 - 2.3800 1-Yr Rtn: -64.71%

Stock Chart for ABIO

No chart data available.
  • ABIO:US 0.7299
  • 1D
  • 1M
  • 1Y
0.7000
Interactive ABIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ABIO

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5400
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M USD) 15.23
Shares Outstanding (M) 21.15
30 Day Average Volume 380,806
Price/Book (mrq) 0.8851
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ABIO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ABIO

Arca biopharma, Inc. develops genetically targeted therapies for heart failure and other cardiovascular diseases.

Michael R BristowPresident/CEOThomas A KeuerChief Operating Officer
Christopher D OzeroffSenior VP/Secretary/Gen CnslBrian SelbyVP:Finance/Chief Acctg Officer
More Company Profile & Key Executives for ABIO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil